fda approval of durvalumab for stage iii unresectable nsclc
Published 6 years ago • 547 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
0:57
dr. patel on the fda approval of durvalumab in nsclc
-
7:44
durvalumab (imfinzi) fda approved for stage iii nsclc: standard of care? (bmic-024)
-
6:06
stage iii nsclc: when to start durvalumab
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
0:58
an expert’s thoughts on the fda approval of durvalumab in locally advanced lung cancers
-
1:49
fda approval of durvalumab for bladder cancer
-
4:43
treating for stage iii nsclc after progression on durvalumab
-
6:22
refining which patients benefit from consolidation durvalumab for stage iii unresectable nsclc
-
2:03
durvalumab fda approval for bladder cancer
-
2:43
fda approves durvalumab / imfinzi for resectable nsclc non-small cell lung cancer
-
6:50
implications for using durvalumab in stage 3 nsclc
-
5:59
durvalumab in stage iii nsclc based on performance status
-
11:30
durvalumab following radiotherapy in patients with unresectable, stage 3 nsclc ineligible for ch...
-
4:37
durvalumab: a new option for stage iii nsclc patients? | davey daniel
-
3:59
pacific trial of durvalumab for stage iii nsclc
-
3:25
impact of radiation dose to immune cells in unresectable or stage iii nsclc in the durvalumab era
-
2:10
dr. langer on the benefit of durvalumab in stage iii nsclc
-
6:07
pacific trial: durvalumab following chemotherapy for stage iii nsclc
-
8:36
pacific trial: durvalumab for stage 3 nsclc